SEC Form 4 · accession 0001209191-16-145419
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory T Went
Officer — Chief Executive Officer · Director
Period of report
Oct 5, 2016
Accepted (ET)
Oct 7, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2016 | J | 117,450 | $0.00 | D | 146,208 | D | |
| Common Stock | Oct 5, 2016 | J | 195,400 | $0.00 | D | 195,392 | I | By Trust |
| Common Stock | holding | — | — | — | 80,000 | I | Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Bridget Elise Went | |
| Common Stock | holding | — | — | — | 80,000 | I | Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Cora Margaret Went |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.665 | Oct 5, 2016 | J | 121,784 | D | — | Nov 16, 2021 | Common Stock | 121,784 | 128,216 | D |
| Stock Option (Right to Buy)F3 | $0.665 | Oct 5, 2016 | J | 27,995 | D | — | Feb 22, 2022 | Common Stock | 27,995 | 32,005 | D |
| Stock Option (Right to Buy)F4 | $8.995 | Oct 5, 2016 | J | 262,963 | D | — | Feb 20, 2024 | Common Stock | 262,963 | 605,037 | D |
| Stock Option (Right to Buy)F5 | $17.31 | Oct 5, 2016 | J | 9,439 | D | — | Feb 24, 2025 | Common Stock | 9,439 | 65,561 | D |
Explanation of responses
- F1Securities disposed of pursuant to a marital separation agreement.
- F2Fully vested.
- F3The Option shares vest as follows: one-fifth (1/5th) of the shares vested one year after February 1, 2012; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of February 1, 2012, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.
- F4The Option shares vest as follows: one-fifth (1/5th) of the shares vest one year after February 20, 2014; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of February 20, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.
- F5The Option vests as follows: 1/48th of the option shares vest on the 1st of each month beginning with March 1, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.